Cita APA (7a ed.)
Giffoni de Mello Morais Mata, D., Pezo, R. C., Chan, K. K. W., Menjak, I., Eisen, A., & Trudeau, M. (2025). A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer. Current Oncology, 32(1), 6-26.
Cita Chicago Style (17a ed.)
Giffoni de Mello Morais Mata, Danilo, Rossanna C. Pezo, Kelvin K. W. Chan, Ines Menjak, Andrea Eisen, y Maureen Trudeau. "A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer." Current Oncology 32, no. 1 (2025): 6-26.
Cita MLA (9a ed.)
Giffoni de Mello Morais Mata, Danilo, et al. "A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer." Current Oncology, vol. 32, no. 1, 2025, pp. 6-26.
Precaución: Estas citas no son 100% exactas.